Today: 28 February 2026
Subscribe
Browse Category

NASDAQ:AZN 1 October 2025 - 11 January 2026

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca will be removed from the Nasdaq-100 on Jan. 20, replaced by Walmart, Nasdaq said Friday. AstraZeneca shares rose 0.28% in London and 0.68% in New York after the announcement. Index funds are expected to adjust holdings near the effective date, potentially increasing trading volume. AstraZeneca management is set to speak at the JPMorgan Healthcare Conference starting Monday.
11 January 2026
····
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

Nasdaq said Friday that Walmart will replace AstraZeneca in the Nasdaq-100 before trading opens Jan. 20. AstraZeneca’s U.S. shares closed at $94.65, up 0.68%, with volume near 6.1 million. Investors are watching AstraZeneca’s management talks at the J.P. Morgan Healthcare Conference Jan. 12–14 and its full-year results on Feb. 10.
10 January 2026
···
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca shares traded near £127.82 ($85 ADR) on Oct. 10, 2025, close to a 52-week high after a U.S. NYSE listing and a $4.5 billion Virginia plant announcement. Market cap stands at $264 billion, with 2024 revenue of $54.1 billion, up 18%. The company agreed to provide U.S. Medicaid with its lowest global drug prices. Shares have rallied over 10% since late September.
11 October 2025
···
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····
Go toTop